Erika Carmel Ltd (BCUR) - Total Assets
Based on the latest financial reports, Erika Carmel Ltd (BCUR) holds total assets worth ILA31.51 Million ILA (≈ $84.49K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore BCUR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Erika Carmel Ltd - Total Assets Trend (2019–2024)
This chart illustrates how Erika Carmel Ltd's total assets have evolved over time, based on quarterly financial data. See Erika Carmel Ltd (BCUR) shareholders funds for net asset value and shareholders' equity analysis.
Erika Carmel Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Erika Carmel Ltd's total assets of ILA31.51 Million consist of 79.4% current assets and 20.6% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 5.2% |
| Accounts Receivable | ILA6.65 Million | 19.1% |
| Inventory | ILA16.41 Million | 47.2% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Erika Carmel Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Erika Carmel Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Erika Carmel Ltd's current assets represent 79.4% of total assets in 2024, an increase from 56.8% in 2019.
- Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, down from 21.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 47.2% of total assets.
Erika Carmel Ltd Competitors by Total Assets
Key competitors of Erika Carmel Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
APT Medical Inc
SHG:688617
|
China | CN¥3.43 Billion |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
Erika Carmel Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.65 | 2.12 | 1.34 |
| Quick Ratio | 0.66 | 1.09 | 1.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA10.36 Million | ILA19.76 Million | ILA3.77 Million |
Erika Carmel Ltd - Advanced Valuation Insights
This section examines the relationship between Erika Carmel Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.99 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -25.9% |
| Total Assets | ILA34.75 Million |
| Market Capitalization | $4.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Erika Carmel Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Erika Carmel Ltd's assets decreased by 25.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Erika Carmel Ltd (2019–2024)
The table below shows the annual total assets of Erika Carmel Ltd from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA34.75 Million ≈ $93.16K |
-25.92% |
| 2023-12-31 | ILA46.91 Million ≈ $125.76K |
-31.41% |
| 2022-12-31 | ILA68.39 Million ≈ $183.34K |
-45.35% |
| 2021-12-31 | ILA125.13 Million ≈ $335.47K |
+162.28% |
| 2020-12-31 | ILA47.71 Million ≈ $127.90K |
+83.06% |
| 2019-12-31 | ILA26.06 Million ≈ $69.87K |
-- |
About Erika Carmel Ltd
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic probl… Read more